Algia Pharma Advances Non-Opioid Pain Treatment to Phase 2
Algia Pharma, LLC announced that it has received FDA support to advance its non-opioid pain treatment, AlgiaPak, toward a Phase 2 clinical trial following completion of Investigational New Drug...